Ruchira Papers Board Announces FY26 Results and Final Dividend Recommendation
Ruchira Papers Limited has announced its audited financial results for the fiscal year ended March 31, 2026, with the board recommending a final dividend.
Ruchira Papers Limited has announced its audited financial results for the fiscal year ended March 31, 2026, with the board recommending a final dividend.
Themis Medicare Limited has submitted its Q4 FY2025-26 financial results to NSE, marking the close of the fiscal year reporting cycle. Market participants are watching for further disclosure of operational metrics.
Century Plyboards (India) Ltd's step-down subsidiary has commenced commercial production at its new resin manufacturing unit in Naidupetta, Andhra Pradesh.
Alkem Laboratories has filed its latest investor presentation with the NSE, giving market participants fresh insight into the company's business outlook and financial positioning.
Palm Jewels has published its audited financial results for the quarter and financial year ended 31 March 2026, adhering to SEBI disclosure norms.
Alkem Laboratories has released its Q4 and full-year FY2026 earnings materials through an official BSE filing, making the press release and analyst presentation accessible to investors.
Procter & Gamble Hygiene and Health Care Limited has announced August 17, 2026, as the record date for dividend eligibility, according to NSE filings.
The board of Rajapalayam Mills has fixed August 21, 2026 as the record date for determining shareholder eligibility for an upcoming dividend.
Reliance Industries has released the notice for its 49th Annual General Meeting, covering the financial year 2025-26, with meeting documents sent through electronic mode to shareholders.
Alkem Laboratories board has set August 7 as the record date for final dividend and August 20 as the AGM cut-off date, as disclosed in a BSE filing.
B. L. Kashyap and Sons Limited has filed its Q4 and full-year financial results for FY2026 ending March 31, 2026 with the National Stock Exchange.
Alkem Laboratories board has recommended a final dividend of Rs 10 per equity share for FY ended March 2025. The proposal awaits shareholder approval at the ensuing Annual General Meeting.
NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.
Need more? Pro tracks up to 500 companies with preferential issue alerts.
No credit card required. Connect WhatsApp or Telegram in minutes.